XOFLUZA
XOFLUZA
Approved
DIN Number
02524163
Drug Class
Human
Market Date
Mar 5, 2025
Company
HC
Hoffmann-La Roche Limited
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02524163
AIG Number0162036003
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
J05AX25 BALOXAVIR MARBOXIL
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification08:18.92
Health Canada Classification
ACTIVE INGREDIENTS (1)
BALOXAVIR MARBOXILActive
Strength: 80 MG
Monograph: BALOXAVIR MARBOXIL